ACAD5:57 PMAcadia Pharmaceuticals to Participate in the Canaccord Genuity 46th Annual Growth Conferenceacadia.com
ACAD9:05 AMAcadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosisacadia.com
ACAD4:05 PMAcadia Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 4, 2026acadia.com